Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
|
|
|
Industry Insights |
|
|
Trends and Challenges to Face the Pharma Industry in 2024
The Clinical Research Organisation (CRO) sector is set for significant transformations in 2024 and faces several challenges. Increased research funding and government support for R&D.
|
|
|
|
|
|
|
|
|
|
New Levels Breached In Drug Discovery By Biology-Driven AI
With the assistance of biology-driven AI, drug development is about to enter an age that will make it even more efficient, effective, as well as affordable.
|
|
|
|
|
|
By Automating Traditional Methods, CROs Stand To Benefit
The continued contract resource organizations use by big pharma necessitates that the former get access to pharmacovigilance automation for better outcomes.
|
|
|
|
|
|
|
|
|
|
AI-Driven Chemistry Laboratories: Newly Proposed Guidelines
Researchers are going to most probably assess the capabilities as well as performance of self-driving labs accurately based on the newly suggested criteria.
|
|
|
|
|
|
To Boost Lab Productivity, Tecan Develops 2 Digital Tools
Two digital tools developed by Tecan, LabNavigator and Next-Gen Introspect, have been introduced to ensure a consistent enhancement of laboratory operations.
|
|
|
|
|
|
|
|
|
|
Cancer Diagnostics Market Outlook 2031: Growth Trends and Insights
The global cancer diagnostics market, valued at USD 163.7 billion in 2021, is anticipated to witness substantial growth, reaching over USD 335.7 billion by 2031
|
|
|
|
|
|